Form4insider filings, from the source

SEC Form 4 · accession 0000921895-16-005904

Enveric Biosciences, Inc. · ENVB

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owners
Jeffrey E. Eberwein
Director · 10% Owner
Period of report
Oct 18, 2016
Accepted (ET)
Oct 21, 2016 · 5:40 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000890821

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Common StockF1,F5Oct 18, 2016L25$6.51A66,259IBy: Separately Managed Account
Common StockF1,F5Oct 19, 2016P400$6.51A66,659IBy: Separately Managed Account
Common StockF1,F5Oct 20, 2016P126$6.51A66,785IBy: Separately Managed Account
Common StockF1,F2holding———1,666,755IBy: Lone Star Value Investors, LP

Table II — derivative securities

No Table II lines on this filing.

Explanation of responses